Xalibo 50mg Injection

Decitabine (50mg) Primary uses of : Ovarian cancer, Head and neck cancer, Cervical cancer
*
₹ 8,100.00 incl tax
Expert advice for Xalibo Injection You should undergo frequent examinations of complete blood count before every dosing cycle to check development of neutropenia (abnormally low white blood cell count) or thrombocytopenia (abnormally low count of platelets in the blood).You should regularly be monitor and treated accordingly for signs and symptoms of infections or any unusual bleeding as decitabine is known to suppress the activity of the immune system and affects blood clotting functions.Take extreme care to avoid pregnancy while on decitabine therapy. Consult your doctor if you get to know that you are pregnant.
Composition Decitabine (50mg)
Potentially Unsafe With Lactation
Side Effect Common Nausea, Vomiting, Headache, Fever, Lung infection, Decreased white blood cell count (neutrophils), Nose bleed, Anemia (low number of red blood cells), Low blood platelets, Diarrhoea, Pneumonia.
How to works How Xalibo Injection works Xalibo 50mg Injection interferes with the growth of DNA and RNA of the cancer cells by substituting their building blocks. It prevents the cancer cells from growing and multiplying.